This mutation already appeared in a subclone (VAF, 0.27) in primary recipient mouse 29 and expanded in the secondary and tertiary recipients, in which all AML cells harbored the Csf3r-d715, RUNX1-RHD, and Cxxc4-ITD mutations (Figure 5B). This evidence concerns the gene CSF3R and acute myeloid leukemia.